Dashboard
The company declared very negative results in Mar'25 after flat results in Dec'24
- NET PROFIT(HY) At USD -5.3 MM has Grown at -113.56%
- INTEREST(HY) At USD 0.45 MM has Grown at 316.32%
- RAW MATERIAL COST(Y) Grown by 47.02% (YoY)
Risky - Negative EBITDA
Falling Participation by Institutional Investors
Below par performance in long term as well as near term
Total Returns (Price + Dividend) 
LM Funding America, Inc. for the last several years.
Risk Adjusted Returns v/s 
News

LM Funding America, Inc. Forms Death Cross, Signaling Bearish Trend Ahead
LM Funding America, Inc. has recently encountered a Death Cross, indicating a potential bearish trend. While daily moving averages reflect a bearish outlook, weekly and monthly indicators show mixed signals. The stock has outperformed the S&P 500 in the short term, but long-term performance remains troubling with significant declines.
Read MoreIs LM Funding America, Inc. technically bullish or bearish?
As of 2 September 2025, the technical trend for LM Funding America, Inc. has changed from mildly bullish to mildly bearish. The current stance is mildly bearish, driven by the weekly MACD indicating bearish momentum and the Bollinger Bands showing a mildly bearish signal. Additionally, the KST is bearish on a monthly basis, and the Dow Theory reflects a mildly bearish outlook as well. The daily moving averages are mildly bullish, but this is overshadowed by the overall bearish indicators. In terms of performance, the stock has significantly underperformed against the S&P 500 across multiple time frames, with a 1-month return of -47.37% compared to the S&P 500's 2.33%, and a 5-year return of -92.57% versus the S&P 500's 96.61%....
Read MoreIs LM Funding America, Inc. overvalued or undervalued?
As of 31 March 2023, the valuation grade for LM Funding America, Inc. moved from does not qualify to risky. The company is overvalued given its significant losses and negative return metrics. Key ratios include a Price to Book Value of 0.32, an EV to EBIT of -0.05, and an EV to EBITDA of -0.11, all indicating poor financial health and valuation concerns. In comparison to peers, LM Funding America, Inc. has a worse EV to EBITDA ratio of -5.2816 compared to BioNexus Gene Lab Corp. at -2.5208 and Greenwave Technology Solutions, Inc. at -1.1607, highlighting its relative underperformance. Additionally, the company's stock has underperformed significantly against the S&P 500, with a 1-year return of -47.15% compared to the index's 17.14%, reinforcing the notion of overvaluation....
Read More Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2025
Shareholding Compare (%holding) 
Domestic Funds
Held in 3 Schemes (1.61%)
Held by 5 Foreign Institutions (0.12%)
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
QoQ Growth in quarter ended Jun 2025 is -20.83% vs 20.00% in Mar 2025
QoQ Growth in quarter ended Jun 2025 is 101.85% vs -384.21% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -15.38% vs 664.71% in Dec 2023
YoY Growth in year ended Dec 2024 is 59.26% vs 32.26% in Dec 2023






